Domain Partners VI, L.P.
Insider CIK 1298033 · ALIM 10% owner · MRNS 10% owner · OCRX 10% owner · RGDO 10% owner · CADX 10% owner · ALDX 10% owner · CLCD 10% owner · SNDX 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| OCRX Ocera Therapeutics, Inc. | D To issuer deriv | 2017-12-11 | 2017-12-13 | 20,150 | — | $0 | 0 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | D To issuer deriv | 2017-12-11 | 2017-12-13 | 20,150 | — | $0 | 0 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | D To issuer | 2017-12-11 | 2017-12-13 | 1,857,036 | — | $0 | 0 | SEC↗ |
| TBRA Tobira Therapeutics, Inc. | U Tender | 2016-11-01 | 2016-11-03 | 285,679 | $28.35 | $8.10M | 0 | SEC↗ |
| CLCD CoLucid Pharmaceuticals, I | J Other | 2016-09-09 | 2016-09-13 | 1,943,109 | — | $0 | 0 | SEC↗ |
| CLCD CoLucid Pharmaceuticals, I | S Sale | 2016-08-03 | 2016-08-03 | 81,094 | $8.15 | $660.9K | 1,943,109 | SEC↗ |
| CLCD CoLucid Pharmaceuticals, I | S Sale | 2016-08-02 | 2016-08-03 | 19,718 | $8.71 | $171.7K | 2,024,203 | SEC↗ |
| CLCD CoLucid Pharmaceuticals, I | S Sale | 2016-08-01 | 2016-08-03 | 52,216 | $8.82 | $460.5K | 2,043,921 | SEC↗ |
| CLCD CoLucid Pharmaceuticals, I | S Sale | 2016-04-28 | 2016-05-02 | 149,765 | $6.96 | $1.04M | 2,096,137 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | C Conversion deriv | 2016-03-08 | 2016-03-08 | 444,460 | — | $0 | 0 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | C Conversion deriv | 2016-03-08 | 2016-03-08 | 1,299,394 | — | $0 | 0 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | C Conversion | 2016-03-08 | 2016-03-08 | 1,743,854 | — | $0 | 1,743,854 | SEC↗ |
| CLCD CoLucid Pharmaceuticals, I | C Conversion deriv | 2015-05-11 | 2015-05-11 | 464,756 | — | $0 | 0 | SEC↗ |
| CLCD CoLucid Pharmaceuticals, I | C Conversion deriv | 2015-05-11 | 2015-05-11 | 939,289 | — | $0 | 0 | SEC↗ |
| CLCD CoLucid Pharmaceuticals, I | C Conversion deriv | 2015-05-11 | 2015-05-11 | 798,188 | — | $0 | 0 | SEC↗ |
| CLCD CoLucid Pharmaceuticals, I | C Conversion | 2015-05-11 | 2015-05-11 | 2,202,233 | — | $0 | 2,245,902 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | C Conversion deriv | 2014-08-05 | 2014-08-07 | 579,630 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | C Conversion deriv | 2014-08-05 | 2014-08-07 | 820,320 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | C Conversion deriv | 2014-08-05 | 2014-08-07 | 657,192 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | C Conversion | 2014-08-05 | 2014-08-07 | 2,057,142 | — | $0 | 2,057,142 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | P Buy | 2014-08-05 | 2014-08-07 | 419,744 | $8.00 | $3.36M | 2,476,886 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | C Conversion deriv | 2014-05-07 | 2014-05-07 | 0 | — | $0 | 0 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | C Conversion | 2014-05-07 | 2014-05-07 | 21,250 | — | $0 | 1,973,389 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | M Exercise deriv | 2014-05-01 | 2014-05-05 | 60,576 | — | $0 | 0 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | M Exercise deriv | 2014-05-01 | 2014-05-05 | 60,576 | — | $0 | 0 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | C Conversion deriv | 2014-05-01 | 2014-05-05 | 755,263 | — | $0 | 0 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | C Conversion deriv | 2014-05-01 | 2014-05-05 | 486,316 | — | $0 | 0 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | M Exercise | 2014-05-01 | 2014-05-05 | 60,576 | $5.16 | $312.6K | 1,969,689 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | F Tax w/h | 2014-05-01 | 2014-05-05 | 39,063 | $8.00 | $312.5K | 1,930,626 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | M Exercise | 2014-05-01 | 2014-05-05 | 60,576 | $5.16 | $312.6K | 1,991,202 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | C Conversion | 2014-05-01 | 2014-05-05 | 1,909,113 | — | $0 | 1,909,113 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | F Tax w/h | 2014-05-01 | 2014-05-05 | 39,063 | $8.00 | $312.5K | 1,952,139 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer | 2014-03-19 | 2014-03-21 | 7,313,241 | $14.00 | $102.39M | 0 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | S Sale | 2014-01-16 | 2014-01-17 | 204,315 | $6.56 | $1.34M | 3,590,931 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | S Sale | 2014-01-15 | 2014-01-17 | 92,445 | $6.01 | $555.6K | 3,795,246 | SEC↗ |
| RGDO Regado Biosciences Inc | C Conversion deriv | 2013-08-27 | 2013-08-28 | 894,120 | — | $0 | 0 | SEC↗ |
| RGDO Regado Biosciences Inc | C Conversion deriv | 2013-08-27 | 2013-08-28 | 270,568 | — | $0 | 0 | SEC↗ |
| RGDO Regado Biosciences Inc | C Conversion deriv | 2013-08-27 | 2013-08-28 | 394,969 | — | $0 | 0 | SEC↗ |
| RGDO Regado Biosciences Inc | C Conversion deriv | 2013-08-27 | 2013-08-28 | 225,913 | — | $0 | 0 | SEC↗ |
| RGDO Regado Biosciences Inc | C Conversion | 2013-08-27 | 2013-08-28 | 225,913 | — | $0 | 1,821,117 | SEC↗ |
| RGDO Regado Biosciences Inc | C Conversion | 2013-08-27 | 2013-08-28 | 394,969 | — | $0 | 430,516 | SEC↗ |
| RGDO Regado Biosciences Inc | C Conversion | 2013-08-27 | 2013-08-28 | 270,568 | — | $0 | 701,084 | SEC↗ |
| RGDO Regado Biosciences Inc | C Conversion | 2013-08-27 | 2013-08-28 | 894,120 | — | $0 | 1,595,204 | SEC↗ |
| RGDO Regado Biosciences Inc | P Buy | 2013-08-27 | 2013-08-28 | 750,000 | $4.00 | $3.00M | 2,571,117 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | P Buy | 2013-07-15 | 2013-07-16 | 331,873 | $6.03 | $2.00M | 1,897,336 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | P Buy | 2013-07-15 | 2013-07-31 | 331,873 | $6.03 | $2.00M | 1,857,036 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | S Sale | 2013-06-20 | 2013-06-24 | 10,516 | $5.01 | $52.7K | 3,887,691 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | S Sale | 2013-06-19 | 2013-06-20 | 22,423 | $5.37 | $120.4K | 3,898,207 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | S Sale | 2013-06-18 | 2013-06-20 | 32,855 | $5.40 | $177.4K | 3,920,630 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | S Sale | 2013-06-17 | 2013-06-18 | 87,812 | $5.40 | $474.2K | 3,953,485 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | S Sale | 2013-06-14 | 2013-06-18 | 38,897 | $5.03 | $195.7K | 4,041,297 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | S Sale | 2013-06-11 | 2013-06-13 | 5,337 | $5.00 | $26.7K | 4,080,194 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | S Sale | 2013-05-16 | 2013-05-17 | 21,276 | $4.50 | $95.7K | 4,085,531 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | S Sale | 2013-05-15 | 2013-05-17 | 22,966 | $4.70 | $107.9K | 4,106,807 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-04-15 | 2013-04-17 | 71,578 | $6.62 | $473.8K | 7,313,241 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-04-10 | 2013-04-10 | 4,832 | $6.72 | $32.5K | 7,384,819 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-04-09 | 2013-04-10 | 35,114 | $6.71 | $235.6K | 7,389,651 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-04-08 | 2013-04-10 | 37,676 | $6.52 | $245.6K | 7,424,765 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-21 | 2013-03-22 | 13,490 | $5.35 | $72.2K | 7,462,441 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-20 | 2013-03-21 | 16,995 | $5.22 | $88.7K | 7,475,931 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-19 | 2013-03-21 | 24,442 | $5.19 | $126.9K | 7,492,926 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-18 | 2013-03-19 | 24,736 | $5.16 | $127.6K | 7,517,368 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-15 | 2013-03-19 | 29,719 | $5.28 | $156.9K | 7,542,104 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-14 | 2013-03-15 | 15,480 | $5.36 | $83.0K | 7,571,823 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-13 | 2013-03-15 | 23,848 | $5.40 | $128.8K | 7,587,303 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-12 | 2013-03-13 | 19,569 | $5.38 | $105.3K | 7,611,151 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-11 | 2013-03-13 | 12,700 | $5.34 | $67.8K | 7,630,720 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-08 | 2013-03-11 | 15,892 | $5.32 | $84.5K | 7,643,420 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-07 | 2013-03-11 | 39,168 | $5.22 | $204.5K | 7,659,312 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-06 | 2013-03-07 | 11,841 | $5.06 | $59.9K | 7,698,480 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-05 | 2013-03-07 | 12,454 | $5.01 | $62.4K | 7,710,321 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-04 | 2013-03-05 | 15,865 | $5.01 | $79.5K | 7,722,775 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-01 | 2013-03-05 | 23,548 | $5.01 | $118.0K | 7,738,640 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-02-20 | 2013-02-22 | 6,160 | $5.01 | $30.9K | 7,762,188 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-02-19 | 2013-02-20 | 31,075 | $5.02 | $156.0K | 7,768,348 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-02-15 | 2013-02-20 | 9,148 | $5.00 | $45.7K | 7,799,423 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-02-14 | 2013-02-15 | 9,100 | $5.01 | $45.6K | 7,808,571 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-02-13 | 2013-02-15 | 17,770 | $5.00 | $88.8K | 7,817,671 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-02-01 | 2013-02-05 | 30,134 | $4.85 | $146.1K | 7,835,441 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-01-31 | 2013-02-01 | 57,165 | $4.71 | $269.2K | 7,865,575 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-01-30 | 2013-02-01 | 34,248 | $5.00 | $171.2K | 7,922,740 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-01-29 | 2013-01-30 | 47,247 | $5.27 | $249.0K | 7,956,988 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-01-28 | 2013-01-30 | 51,377 | $5.40 | $277.4K | 8,004,235 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-01-25 | 2013-01-28 | 42,525 | $5.38 | $228.8K | 8,055,612 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-01-25 | 2013-01-29 | 42,525 | $5.38 | $228.8K | 8,055,612 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-01-24 | 2013-01-28 | 111,022 | $5.45 | $605.1K | 8,098,137 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-01-24 | 2013-01-29 | 112,022 | $5.45 | $610.5K | 8,098,137 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-01-23 | 2013-01-24 | 78,188 | $5.11 | $399.5K | 8,210,159 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-01-22 | 2013-01-24 | 46,153 | $5.02 | $231.7K | 8,288,347 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-01-18 | 2013-01-22 | 58,838 | $5.19 | $305.4K | 8,334,500 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-01-17 | 2013-01-22 | 38,903 | $5.35 | $208.1K | 8,393,338 | SEC↗ |